Compare BIO & PSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | PSN |
|---|---|---|
| Founded | 1952 | 1944 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | EDP Services |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 9.2B |
| IPO Year | N/A | 2019 |
| Metric | BIO | PSN |
|---|---|---|
| Price | $304.33 | $61.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 14 |
| Target Price | ★ $358.50 | $85.77 |
| AVG Volume (30 Days) | 158.4K | ★ 1.9M |
| Earning Date | 10-29-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.02 |
| EPS | N/A | ★ 2.17 |
| Revenue | $2,557,500,000.00 | ★ $6,494,748,000.00 |
| Revenue This Year | $1.77 | N/A |
| Revenue Next Year | $2.30 | $5.69 |
| P/E Ratio | ★ N/A | $29.19 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $211.43 | $54.56 |
| 52 Week High | $373.69 | $99.04 |
| Indicator | BIO | PSN |
|---|---|---|
| Relative Strength Index (RSI) | 42.52 | 24.37 |
| Support Level | $307.08 | $61.85 |
| Resistance Level | $319.50 | $67.36 |
| Average True Range (ATR) | 8.41 | 2.83 |
| MACD | -1.74 | -1.97 |
| Stochastic Oscillator | 10.83 | 1.68 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe.